Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Mamm Genome. 2011 Oct 22;22(11-12):714–721. doi: 10.1007/s00335-011-9360-4

Additive effect of TAp63 deficiency on the adrenocortical dysplasia (acd) phenotype

Bridget C O’Connor 1, Erica L Macke 2, Catherine E Keegan 3
PMCID: PMC3298752  NIHMSID: NIHMS354019  PMID: 22038471

Abstract

Adrenocortical dysplasia (acd) is a spontaneous autosomal recessive mouse mutation exhibiting caudal truncation, vertebral segmentation defects, hydronephrosis, limb hypoplasia, and perinatal lethality. Acd encodes TPP1, a component of the shelterin complex that maintains telomere integrity, and consequently acd mutant mice have telomere dysfunction and genomic instability. We previously showed that apoptosis is the primary mechanism causing the acd skeletal phenotype, and that p53 deficiency rescues the skeletal defects of the acd phenotype but has no effect on the perinatal lethality. The Trp63 gene encodes multiple isoforms, which play a role in proliferation, apoptosis, and stem/progenitor cell maintenance. Different p63 isoforms exhibit both proapoptotic (TAp63) and antiapoptotic (DNp63) functions. We hypothesized that deficiency of proapoptotic TAp63 isoforms might rescue the acd skeletal phenotype, similar to our previous observations with deficiency of p53. Mice heterozygous for a null allele of TAp63 were crossed to heterozygous acd mice to determine the effect of TAp63 deficiency on the acd mutant phenotype. In contrast to our results with the acd × p53 cross, skeletal anomalies were not rescued by deficiency of TAp63. In fact, the limb and vertebral anomalies observed in double-mutant embryos were more severe than those of embryos with the acd mutation alone, demonstrating a dose-dependent effect. These studies suggest that TAp63 isoforms do not facilitate p53-like apoptosis during development in response to acd-mediated telomere dysfunction and are consistent with the proposed roles of TAp63 in maintaining genomic stability.

Introduction

Adrenocortical dysplasia (Acdacd, hereafter denoted acd) is an autosomal recessive mouse mutation caused by a splicing defect in the Acd gene, which encodes Tpp1, a component of the shelterin telomere complex (Keegan et al.2005). The acd mutation results in a RNA splicing defect and is a hypomorphic allele, likely due to residual production of a small amount of appropriately spliced wild-type Acd mRNA (Else et al. 2007). Homozygous mutant acd mice survive into adulthood on a mixed genetic background with the CAST/Ei strain and have a phenotype consisting of growth retardation, infertility, skin hyperpigmentation, and hypoplastic adrenal glands. Mutant mice do not survive for a significant period of time past birth on the DW/J strain, on which the mutation arose, or on the C57BL6/J (B6) strain (Vlangos et al. 2009). Interestingly, the phenotype of mutant embryos on these latter strains is characterized by caudal truncation with limb hypoplasia, predominantly affecting the lower limbs, and vertebral segmentation defects, resembling caudal regression syndrome in humans (Keegan et al. 2005). Complete deficiency of Acd/Tpp1 results in early embryonic lethality, similar to knockout alleles of other shelterin components (Kibe et al. 2010).

The primary function of Tpp1 is to recruit the single-stranded DNA binding protein(s) Pot1 (a and b) to the telomere and to facilitate binding of Pot1 to the remainder of the shelterin complex and to the single-stranded telomeric DNA overhang (Hockemeyer et al. 2007; Kibe et al. 2010). Tpp1 also physically interacts with the enzymatic component of the telomerase holoenzyme (TERT) and is necessary for recruitment of telomerase to telomeres (Abreu et al. 2010; Wang et al. 2007; Xin et al. 2007). Together, Tpp1 and Pot1 protect chromosome ends from being recognized and processed by the DNA repair machinery as well as recruit telomerase to telomeres. Disruption of Tpp1 and/or Pot1 causes deprotection of the telomeres, resulting in activation of p53 signaling via ATR (Kibe et al. 2010; Rai et al. 2010). Our previous work demonstrated that the skeletal defects observed in acd mutant embryos were caused by p53-dependent apoptosis during development (Vlangos et al. 2009). While p53 deficiency did not rescue the perinatal lethality of the acd mutation on the B6 background, the vertebral and limb malformations were rescued by p53 deficiency. When acd mutant mice on a mixed CAST/Ei background were crossed to p53-deficient mice, a partial phenotypic rescue was observed at the expense of increased numbers of tumors in adult mice (Else et al. 2009).

p53 is a member of a family of transcription factors that encompasses three proteins, p53, p63, and p73 (Yang et al. 2002). p53 was the first family member to be discovered and is widely known for its role in genome surveillance and as a tumor suppressor gene. p63 and p73 have been found to have important roles during development. In particular, p63 is critical for development of mesodermal and ectodermal lineages; mutations in TRP63 have been identified in individuals with specific ectodermal dysplasias and disorders of clefting, including EEC (ectrodactyly-ectodermal dysplasia-cleft lip/palate), Hay Wells, and limb-mammary syndromes (Brunner et al. 2002). Limb malformations in individuals with these syndromes characteristically include split hand/split foot malformation, defined by central ray reduction defects. Within the p53 family, p53 is the simplest protein, containing only one isoform with a transactivation (TA) domain at the N-terminus and a single C-terminus. Both p63 and p73 contain multiple protein isoforms, with either a TA domain at the N-terminus or a ΔN domain, which lacks transactivation properties. Additionally, both p63 and p73 have at least three different C-termini. Earlier studies showed that p63 TA-domain-containing isoforms exhibit proapoptotic activity, similar to p53, and it is thought that the ΔN isoforms exhibit antiapoptotic activity in a dominant negative manner with respect to p53 (Yang et al. 1998). Both p63 and p73 cooperate with p53 to mediate apoptosis in response to DNA damage (Flores et al. 2002), and additional studies have suggested that p63 and p73 both play a role as tumor suppressor genes (Flores et al. 2005).

Deletion of the DNA binding domain of the Trp63 gene in the mouse, and thus knockout of all p63 isoforms, revealed a critical function in the development of epithelial tissues and limbs. Homozygous mutant mice died within 24 h of birth with craniofacial abnormalities, severely truncated limbs, and failure to form a differentiated squamous cell epithelium in the skin. In addition, the progenitor cell population of the basal layer of the epidermis and the apical ectodermal ridge of the limb, where p63 is strongly expressed, were significantly reduced in p63−/− embryos. Based on these findings, it was hypothesized that p63 plays an important role in the maintenance of progenitor cell populations in these tissues (Mills et al. 1999; Yang et al. 1999).

Knockout of the TA-domain-containing (proapoptotic) isoforms of p63 was shown to be important for protecting the female germline from DNA damage, indicating that p63 also plays a role in surveillance of the genome (Suh et al. 2006). These TA-isoform-specific knockout mice were otherwise viable and fertile with a mild phenotype in comparison to mice with knockout of all isoforms of p63. More recent studies of TA-isoform-specific knockout mice have shown that TAp63 is also critical for maintenance of adult skin stem cells (Su et al. 2009). In the absence of TAp63, cells undergo early senescence and exhibit features of premature aging and genomic instability. Development of the skin was normal in these mice, suggesting that the ΔNp63 isoforms are primarily responsible for epithelial development.

Because of the proposed role of TAp63 as a proapoptotic isoform of p63 with properties similar to p53, and given our previous study demonstrating rescue of acd mutant skeletal phenotypes but not perinatal lethality by p53 deficiency, we hypothesized that deficiency of TAp63 might also rescue developmental phenotypes associated with the acd mutation. In order to test this hypothesis, we crossed acd mice to TA-isoform-specific Trp63tm2Fmc (hereafter referred to as TAp63)-knockout mice to determine whether TAp63 deficiency could rescue the skeletal defects, similar to what we observed with p53 deficiency, or the perinatal lethality of the acd mutation. Our data show that TAp63 deficiency does not rescue the perinatal lethality of the acd mutation. Furthermore, the skeletal malformations in acd mutant embryos are dramatically exacerbated by deficiency of TAp63, indicating an additive effect. Our results support a role for TAp63 in maintaining genomic stability but not in a “proapoptotic” role in this setting.

Materials and methods

Mice

We have maintained an acd breeding colony at the University of Michigan since 2000 when DW/J heterozygous acd animals were obtained from cryopreserved stock (stock No. 001595) at the Jackson Laboratory (Bar Harbor, ME, USA) (Keegan et al. 2005). Heterozygous acd mice were backcrossed to C57BL6/J mice. The data presented here represent embryos from backcross generation N8. Trp63tm2Fmc mice, maintained on a mixed 129S4/SvJae/Balb/c background (hereafter denoted 129S4/Balb/c), were obtained from Dr. Frank McKeon at Harvard University (Suh et al. 2006). Mice were housed in specific pathogen-free and environmentally controlled conditions with 14-h light/10-h dark cycles. Food and water were provided ad libitum. All experiments involving mice were approved by The University of Michigan University Committee on Use and Care of Animals.

Timed pregnancies

Matings for timed pregnancies were set up using standard animal husbandry techniques. Noon of the day that a vaginal plug was observed was considered E0.5. DNA was isolated from yolk sac as previously described (Keegan et al. 2005; Truett et al. 2000).

Genotyping

Genotyping for the acd mutation was performed on DNA from yolk sac or tail biopsy at 10–15 days of age as previously described (Keegan et al. 2005). Genotyping for the TAp63-knockout allele was performed using the primers TAKO4: 5′-ATCTAGCAGCAAGATTAACA A-3′, TAKO5: 5′-GGGAACTTCCTGACTAGGG-3′, and TAKO6: 5′-GCATAGTTCCTACGTTTCAC-3′. TAKO4 and TAKO6 are located just 5′ of exon 2 of the Trp63 gene, and TAKO5 is located within the Neomycin cassette. PCR using an annealing temperature of 61°C and 30 cycles generated a product of 579 bp representing the wild-type allele and a product of 334 bp representing the knockout allele (data not shown).

TAp63 × acd intercross and skeletal analysis

Heterozygous TAp63-null mice (mixed 129S4/Balb/c background) were crossed to acd heterozygous mice (C57BL/6 background, N8 generation). Resulting double-heterozygous mice (acd/+; TAp63+/−) were intercrossed to generate double-homozygous mutant mice (acd/acd; TAp63−/−). The number of pups per litter was recorded within 24 h of birth. Genotype distributions at weaning age (p21) and embryonic day (E)15.5–E16.5 were analyzed by χ2 to determine whether the genotypes were present in expected Mendelian ratios. Embryos were dissected at E15.5–E16.5 in fresh PBS and immediately fixed in 95% ethanol for 4 h. Skeletal staining with Alcian blue and Alizarin red was performed as previously described (Kimmel and Trammell 1981). Stained skeletons were analyzed for morphological abnormalities under a Leica MZ7.5 dissecting microscope. Forelimbs and hindlimbs were designated as normal or abnormal, and specific phenotypes, such as hypoplastic or absent digits, split digits, and absent radii/tibiae, were recorded. The percentage of abnormal/fused vertebrae per embryo was generated by dividing the average number of abnormal/fused vertebrae per embryo by the total number of vertebrae per embryo. Fisher’s exact tests (limbs) and unpaired Student’s t-tests (vertebrae) were performed to determine statistical significance (www.langsrud.com/fisher.htm).

Results

TAp63-null mice exhibit perinatal lethality

To determine whether deficiency of the TAp63 isoform rescues the perinatal lethality of the acd mutation, we first crossed acd/+ mice to TAp63+/− mice and then analyzed progeny of double-heterozygote intercrosses. Data regarding the number of pups per litter were recorded for 21 of 25 litters (115 of the 132 mice) used in the genotyping analysis. Only two mice were missing from this cohort at the time of ear tag placement at 10–15 days of age. Two additional mice died between ear tag placement and weaning (genotypes acd/acd; TAp63+/− and +/+; TAp63+/−). No external malformations, skin lesions, or ulcerations were noted in any of the surviving mice. We found no surviving double-mutant mice at weaning age (n = 132, χ2 = 83.29, df = 8, p < 0.0005) (Table 1). However, we observed two acd/acd; TAp63+/− and four acd/acd; TAp63+/− mice. These mice were phenotypically similar to surviving acd mutant mice on the CAST/Ei background (data not shown). The TAp63-null mice are on a mixed 129S4/Balb/c background, which is likely the reason for the improved survival of the acd mutation compared to the B6 background (CEK, unpublished observations). Of note, we did not observe any surviving TAp63−/− mice, although it has previously been reported that these mice are viable and fertile (Suh et al. 2006). Our data suggest that the TAp63-null mice in our cross most likely died in the perinatal period. This finding is also likely due to genetic background effects.

Table 1.

Genotypes of (acd/+ × TAp63+/−) F2 progeny at weaning

Acd genotypea TAp63 genotypeb
+/+ +/− −/−
+/+ 15 28 0
acd/+ 30 53 0
acd/acd 2 4 0
a

acd denotes mutant allele

b

– denotes TAp63-null allele

χ2 = 83.29, df = 8, p < 0.0005 for predicted Mendelian ratios

TAp63 deficiency exacerbates the limb malformations in acd mutant embryos

To determine whether deficiency of the TAp63 isoform has an effect on the skeletal phenotype of acd mutant embryos, we collected embryos at E15.5–E16.5 and analyzed skeletal elements by staining with Alcian blue and Alizarin red. At E15.5-E16.5, we observed Mendelian ratios for the genotype distribution (Table 2). Overall, we observed an increase in the number and severity of limb malformations in both the forelimbs and the hindlimbs of the embryos from this cross (Tables 3, 4, 5) compared to acd mutant embryos and embryos from the acd × p53 cross (Keegan et al. 2005; Vlangos et al. 2009). The majority of acd/acd; TAp63+/+ forelimbs were normal, consistent with previous studies (Keegan et al. 2005) (Fig. 1b). However, none of the acd/acd; TAp63−/− forelimbs were normal (Tables 3,5; Fig. 1d). Abnormal phenotypes consisted of hypoplastic or absent digits, missing metacarpals, and absent radii. One embryo (acd/+; TAp63−/−) had a bifid digit; no embryos had polydactyly. In addition, forelimb anomalies were found in a large percentage of acd/+; TAp63−/− embryos and acd/acd; TAp63+/− embryos (35% and 54%, respectively), suggesting that the effects of Acd and TAp63 deficiency are additive. However, the forelimb abnormalities in acd/+; TAp63−/− embryos were more severe, with absent digits and split-hand malformations. The percentage of abnormal forelimbs increased with increasing numbers of mutant alleles (Table 3). This effect was statistically significant by Fisher’s exact test for 2 vs. 3 mutant alleles (p = 1 × 10−8), 2 vs. 4 mutant alleles (p < 1 × 10−8), and 3 vs. 4 mutant alleles (p < 0.0002), indicating a dosage-sensitive effect. For the hindlimbs, in general, a higher percentage of abnormalities and more severe abnormalities were observed. None of the hindlimbs in double-mutant embryos were normal (Fig. 1h; Tables 4 and 5). However, several acd/acd; TAp63+/+ embryos had limb hypoplasia phenotypes, consistent with previous observations (Keegan et al. 2005). Of note, 19 embryos with split-hand or -foot malformations were observed, which has been reported frequently in humans with TRP63 mutations (Brunner et al. 2002). The majority of embryos (16 of 19) with split-hand/foot malformation had TAp63−/− genotypes. An increase in the percentage of abnormal limbs with an increasing number of mutant alleles was also noted in the hindlimbs, again indicating a dosage-sensitive effect (Table 4). This effect was statistically significant for all comparisons [0 or 1 vs. 2 mutant alleles (p = 0.004), 2 vs. 3 mutant alleles (p = 0.0012), 2 vs. 4 mutant alleles (p < 1 × 10−8), and 3 vs. 4 mutant alleles (p = 0.00043)] by Fisher’s exact test.

Table 2.

Genotypes of (acd/+ × TAp63+/−) F2 progeny at E15.5

Acd genotypea TAp63 genotypeb
+/+ +/− −/−
+/+ 3 17 7
acd/+ 17 26 10
acd/acd 5 12 8
a

acd denotes mutant allele

b

– denotes TAp63-null allele

χ2 = 5.8, df = 8, 0.70 < p < 0.60 for predicted Mendelian ratios

Table 3.

(acd/+ × TAp63+/−) intercross embryo forelimb phenotypesa

Genotypes
(Acd; TAp63)
No. of
forelimbs
No. of mutant
allelesb
No. (%)
abnormal
+/+; +/+ 6 0 0 (0%)
+/+; +/− 34 1 0 (0%)
acd/+; +/+ 34 1 0 (0%)
+/+; −/− 14 2 0 (0%)
acd/+; +/− 52 2 0 (0%)
acd/acd; +/+ 10 2 2 (20%)
acd/+; −/− 20 3 7 (35%)
acd/acd; +/− 24 3 13 (54%)
acd/acd; −/− 16 4 16 (100%)
Total 210
a

Numerical values represent number and (percentage) of forelimbs with each phenotype

b

Statistically significant by Fisher’s exact test for 2 vs. 3 mutant alleles (p = 1 × 10−8), 2 vs. 4 mutant alleles (p < 1 × 10−8), and 3 vs. 4 mutant alleles (p = 0.00018)

Table 4.

(acd/+ × TAp63+/−) intercross embryo hindlimb phenotypesa

Genotypes
(Acd; TAp63)
No. of
hindlimbs
No. of mutant
allelesb
No. (%)
abnormal
+/+; +/+ 6 0 0 (0%)
+/+; +/− 34 1 4 (12%)
acd/+; +/+ 34 1 0 (0%)
+/+; −/− 14 2 6 (43%)
acd/+; +/− 52 2 5 (10%)
acd/acd; +/+ 10 2 6 (60%)
acd/+; −/− 20 3 6 (30%)
acd/acd; +/− 24 3 17 (71%)
acd/acd; −/− 16 4 16 (100%)
Total 210
a

Numerical values represent number and (percentage) of hindlimbs with each phenotype

b

Statistically significant by Fisher’s exact test for 0 or 1 vs. 2 mutant alleles (p = 0.004), 2 vs. 3 mutant alleles (p = 0.0012), 2 vs. 4 mutant alleles (p < 1 × 10−8), and 3 vs. 4 mutant alleles (p = 0.00043)

Table 5.

Comparison of acd/acd; TAp63+/− and acd/acd; TAp63−/− limb phenotypesa

acd/acd;
TAp63+/−
n = 24
acd/acd;
TAp63−/−
n = 16
Forelimbs
 Normal 14 (58%) 0 (0%)
 Hypoplastic 1st digit 8 (33%) 1 (6%)
 Absent digits 2 (8%) 13 (81%)
 Split digits 0 (0%) 2 (13%)
 Hypoplastic/absent radius 0 (0%) 12 (75%)
Hindlimbs
 Normal 6 (25%) 0 (0%)
 Hypoplastic 1st digit 4 (17%) 1 (6%)
 Bifid digits 5 (21%) 0 (0%)
 Absent digits 8 (33%) 15 (94%)
 Split digits 2 (8%) 9 (56%)
 Hypoplastic/absent tibia 3 (13%) 13 (81%)
a

Numerical values represent number and (percentage) of embryos with each phenotype; some embryos exhibited multiple phenotypes

Fig. 1.

Fig. 1

TAp63 deficiency significantly exacerbates acd mutant limb phenotype. Skeletal staining of E15.5 embryos from acd × TAp63 intercross. a, e Wild-type (+/+; TAp63+/+) control showing normal forelimb (a) and hindlimb (e) phenotypes. b–d E15.5 embryo forelimbs. f–h E15.5 embryo hindlimbs. acd/acd;TAp63+/+ (a, e) have a phenotype similar to acd/acd; p53+/+ embryos, with a normal forelimb and absent digits and tibia in the hindlimb. acd/acd;TAp63+/− embryos have normal forelimbs (b) or minor abnormalities such as a hypoplastic first digit, but an abnormal phenotype in the hindlimbs (f) ranging from bifid digits to absent digits and absent or hypoplastic tibiae. acd/acd; TAp63−/− embryos (c, g) have the most severe phenotype, with missing digits and limb bones in both forelimbs and hindlimbs

A comparison of specific limb phenotypes between acd/acd; TAp63+/− and acd/acd; TAp63−/− embryos also supports an additive effect in both the forelimbs and the hindlimbs (Table 5). The most common forelimb malformation in acd/acd; TAp63+/− embryos was a hypoplastic 1st digit, present in 33% of forelimbs, while the majority of acd/acd; TAp63−/− embryos had absent digits (81%) and hypoplastic or absent radii (75%). The increased severity in acd/acd; TAp63−/− embryos was even more pronounced in the hindlimbs, with 94% of embryos having absent digits and 81% having hypoplastic or absent tibiae.

TAp63 deficiency does not rescue vertebral fusions in acd mutant embryos

We previously observed multiple vertebral fusions in acd/acd embryos, which were rescued by deficiency of p53 (Vlangos et al. 2009). In the present cross, we observed significant vertebral abnormalities in all acd/acd embryos, regardless of TAp63 genotype (Fig. 2; Table 6). The abnormalities included a significant reduction in the number of tail vertebrae and multiple vertebral fusions. The percentage of abnormal vertebrae per embryo was statistically significant for acd/acd; TAp63+/− and acd/acd; TAp63−/− embryos vs. wild-type (+/+; TAp63+/+) controls by t-test (Table 6). While the percent abnormal vertebrae per embryo did not reach statistical significance in acd/acd; TAp63+/+ embryos compared to wild-type controls, this is likely due to low numbers of embryos in both of these groups (Table 6). Although the percentage of abnormal vertebrae per embryo trended higher in acd/acd; TAp63−/− embryos compared to acd/acd; TAp63+/− embryos, it did not reach statistical significance (Fig. 2; Table 6). Vertebral anomalies were observed only in embryos with homozygous acd mutant genotypes, suggesting that TAp63 deficiency alone is not sufficient to cause vertebral anomalies. We also observed a few acd mutant embryos with microphthalmia, rib fusions, and exencephaly, as previously described (Table 7) (Vlangos et al. 2009).

Fig. 2.

Fig. 2

TAp63 deficiency exacerbates acd mutant vertebral anomalies. Skeletal staining of E15.5 embryos from acd × TAp63 inter-cross. a Wild-type (+/+; TAp63+/+) control showing normal vertebrae. b–d Thoracic, lumbar, and sacral vertebrae of E15.5 embryos showing vertebral fusions in acd/acd; TAp63+/+, acd/acd; TAp63+/−, and acd/acd; TAp63−/− embryos. e Quantification of percent abnormal vertebrae in each embryo. Although not statistically significant, there is a trend toward increasing severity with increasing TAp63 deficiency

Table 6.

Vertebral anomalies in (acd/+ × TAp63+/−) F2 progeny

Genotypes
(Acd; TAp63)
No. embryos Avg No. vertebrae
per embryo
Avg No. abnormal
vertebrae per embryo
Avg % abnormal
vertebrae per embryoa
+/+; +/+ 3 57.5 0 0
+/+; +/− 17 55.4 2.6 4.7
+/+; −/− 7 56.5 0.9 1.6
acd/+; +/+ 17 58.0 0.7 1.2
acd/+; +/− 26 57.1 0.7 1.2
acd/+; −/− 10 56.2 0.9 1.6
acd/acd; +/+ 5 46.4 13.2 28.4
acd/acd; +/− 12 51.2 19.9 38.9
acd/acd; −/− 8 51.8 24.1 46.5
Total 105
a

Statistically significant difference observed between acd/acd; TAp63+/− vs. +/+; TAp63+/+ (p < 0.005) and acd/acd; TAp63−/− vs. +/+; TAp63+/+ (p < 0.005) by t-test. No significant difference between acd/acd; TAp63+/+ vs. acd/acd; TAp63+/− and between acd/acd; TAp63+/+ vs. acd/acd; TAp63−/− by t-test

Table 7.

(acd/+ × TAp63+/−) intercross embryo phenotypesa

Genotypes
(Acd; TAp63)
No. of
embryos
Microphthalmia Fused
ribs
Exencephaly
+/+; +/+ 3 - - -
+/+; +/− 17 - - -
+/+; −/− 7 - - -
acd/+; +/+ 17 - 1 -
acd/+; +/− 26 1 - -
acd/+; −/− 10 - - -
acd/acd; +/+ 5 - 1 1
acd/acd; +/− 12 4 - 1
acd/acd;−/− 8 2 2 2
Total 105
a

Numerical values represent number of embryos with each phenotype; – indicates 0 embryos with phenotype

Discussion

Our previous studies showed rescue of acd skeletal defects by p53 deficiency and demonstrated that p53-dependent apoptosis is the predominant mechanism leading to skeletal malformations in acd mutant embryos (Vlangos et al.2009). However, p53 deficiency did not rescue the perinatal lethality of the acd mutation on the C57BL6/J background. Previous studies suggested that the TA isoform of p63 is proapoptotic and plays a role in genome surveillance (Suh et al. 2006; Yang et al. 1998). Based on this information, we hypothesized that deficiency of the TAp63 isoform might also rescue the skeletal phenotype of acd mutant mice, thus supporting a proapoptotic role for p63 during embryonic development. Our results do not support this hypothesis, and, in fact, our data demonstrated overall worsening of the skeletal phenotype in acd/acd; TAp63−/− embryos. We found a limb phenotype similar to that previously described in acd/acd; TAp63+/+ embryos, primarily affecting the hindlimbs. In contrast, none of the hindlimbs or forelimbs were normal in acd/acd; TAp63−/− embryos. In addition, only 57% of the hindlimbs were normal in +/+; TAp63−/− embryos, indicating that deficiency of TAp63 alone is sufficient to cause limb abnormalities. Furthermore, we found a statistically significant difference in the percentage of abnormal hindlimbs and forelimbs with an increasing number of mutant alleles, indicating a dose-dependent effect. We also observed several TAp63-deficient embryos with split-foot malformations, which are commonly observed in humans with TRP63 mutations (Brunner et al. 2002). Although different syndromic phenotypes caused by TRP63 mutations tend to cluster in specific functional domains of p63 (Brunner et al.2002), the mutations affecting the limbs in EEC (ectrodactyly-ectodermal dysplasia-cleft lip/palate) syndrome and isolated split-hand/split-foot malformation (SHFM) tend to cluster in the DNA binding domain and would be expected to affect all isoforms of p63.

The vertebral fusions also appeared to be exacerbated by increasing dosage of TAp63 deficiency, although this did not reach statistical significance. However, deficiency of TAp63 alone did not have a significant effect on vertebral formation. This is also consistent with lack of vertebral anomalies in humans with TRP63 mutations (Brunner et al.2002). Therefore, we conclude from these studies that rescue of the acd skeletal phenotype shows specificity for p53, and that the roles of p53 and TAp63 do not overlap during development in the setting of Acd deficiency. While the TAp63-knockout mice used in our study, which had been maintained on a mixed 129S4/Balb/c background, were previously reported to be viable and fertile (Suh et al.2006), we did not observe any TAp63-knockout mice that survived beyond 24 h of life. This phenotypic difference is likely due to increased contribution of the C57BL/6 background from our cross, which is supported by increased embryonic lethality of TAp63-null mice with increasing B6 contribution in other studies (Su et al. 2009).

Previous studies of p63 have suggested an antiapoptotic role for the ΔN isoform and a proapoptotic role for the TA isoform, and a balance of these opposing isoforms is thought to be required for normal function (Yang et al.1998). However, a recent study has helped to clarify the role of the TAp63 isoform in the skin (Su et al. 2009). In that study, mice with a complete knockout of TAp63 had normal development of the skin but developed blisters and skin ulcerations in adulthood, and examination of skin stem and progenitor cells revealed early senescence, evidence of genomic instability with multiple chromosomal aberrations, and increased apoptosis. Deficiency of p53 in the setting of TAp63 deficiency did not rescue the senescence phenotype, yet it did rescue the apoptosis phenotype. TAp63 deficiency also led to early hyperproliferation followed by premature senescence, possibly leading to stem cell exhaustion, as has been observed in other mouse models with telomere dysfunction (Lee et al. 1998; Rudolph et al. 1999). The hyperproliferative phenotype in TAp63-deficient mice was thought to be due to inhibition of the cyclin-dependent kinase inhibitor p57kip2 (Su et al. 2009). However, other studies have shown that TAp63 functions to induce senescence independently of p53 when transfected into MEF cells (Guo et al. 2009); thus, the role of TAp63 in induction of senescence is not clear. While the exact mechanism by which TAp63 functions to maintain genomic stability is not currently known, expression of TAp63 increases in response to stress, similar to p53 (Su et al. 2009), and it is possible that the role of TAp63 in the maintenance of genomic stability may be related to its role as a transcriptional regulator.

Several aspects of our study support a role for TAp63 in maintaining genomic stability. First, the dose-dependent worsening of the acd mutant limb phenotype by TAp63 deficiency suggests that both proteins function in similar or overlapping pathways during limb development. Interestingly, stem cell exhaustion has been proposed as a mechanism in both the TAp63-knockout model and in mouse models of telomere dysfunction (Lee et al. 1998; Rudolph et al. 1999; Su et al. 2009). Second, p53 deficiency partially rescues mutant phenotypes in both the acd and the TAp63-knockout model (Su et al. 2009; Vlangos et al. 2009). We hypothesize that intact p53, in this model, likely acts to drive cells with genomic instability to undergo apoptosis. However, further studies examining for cellular features of genomic instability and evaluating the effect of p53 deficiency in the current cross will be required to test this hypothesis. In addition, because both Acd and TAp63 are highly expressed in epithelial tissues, it may be interesting to examine the interaction of these proteins in the skin. These studies might be feasible on an alternative genetic background in which both mutant alleles are compatible with survival. Although the acd mutant allele is hypomorphic, the study of its characteristic embryonic pheno-type will allow us to answer some of these important questions.

Acknowledgments

The authors thank Andrea Krause for technical assistance. We also thank Dr. Jeffrey Innis and Dr. Christopher Vlangos for critically reading the manuscript, and Dr. Frank McKeon for generously providing the TAp63-knockout mice. We acknowledge the DNA Sequencing Core of the University of Michigan’s Biomedical Research Core Facilities. Core support was provided by The University of Michigan Cancer Center (CA46592) and the Michigan Diabetes Research and Training Center (DK020572). This work was supported by NIH grant R01-HD058606 and a March of Dimes Research Grant No. 1-FY08-431 to CEK.

Contributor Information

Bridget C. O’Connor, Department of Pediatrics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA; Department of Human Genetics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA

Erica L. Macke, Department of Pediatrics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA; Department of Human Genetics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA

Catherine E. Keegan, Department of Pediatrics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA; Department of Human Genetics, University of Michigan, 1150 W. Medical Center Dr., 3520C MSRB I, Box 5652, Ann Arbor, MI 48109-5652, USA

References

  1. Abreu E, Aritonovska E, Reichenbach P, Cristofari G, Culp B, Terns RM, Lingner J, Terns MP. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol. 2010;30:2971–2982. doi: 10.1128/MCB.00240-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brunner HG, Hamel BC, Bokhoven Hv H. P63 gene mutations and human developmental syndromes. Am J Med Genet. 2002;112:284–290. doi: 10.1002/ajmg.10778. [DOI] [PubMed] [Google Scholar]
  3. Else T, Theisen BK, Wu Y, Hutz JE, Keegan CE, Hammer GD, Ferguson DO. Tpp1/Acd maintains genomic stability through a complex role in telomere protection. Chromosome Res. 2007;15:1001–1013. doi: 10.1007/s10577-007-1175-5. [DOI] [PubMed] [Google Scholar]
  4. Else T, Trovato A, Kim AC, Wu Y, Ferguson DO, Kuick RD, Lucas PC, Hammer GD. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell. 2009;15:465–476. doi: 10.1016/j.ccr.2009.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002;416:560–564. doi: 10.1038/416560a. [DOI] [PubMed] [Google Scholar]
  6. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, Yang A, McKeon F, Jacks T. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell. 2005;7:363–373. doi: 10.1016/j.ccr.2005.02.019. [DOI] [PubMed] [Google Scholar]
  7. Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW, Vogel H, Mills AA. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol. 2009;11:1451–1457. doi: 10.1038/ncb1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hockemeyer D, Palm W, Else T, Daniels JP, Takai KK, Ye JZ, Keegan CE, de Lange T, Hammer GD. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat Struct Mol Biol. 2007;14:754–761. doi: 10.1038/nsmb1270. [DOI] [PubMed] [Google Scholar]
  9. Keegan CE, Hutz JE, Else T, Adamska M, Shah SP, Kent AE, Howes JM, Beamer WG, Hammer GD. Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Hum Mol Genet. 2005;14:113–123. doi: 10.1093/hmg/ddi011. [DOI] [PubMed] [Google Scholar]
  10. Kibe T, Osawa GA, Keegan CE, de Lange T. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol Cell Biol. 2010;30:1059–1066. doi: 10.1128/MCB.01498-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kimmel CA, Trammell C. A rapid procedure for routine double staining of cartilage and bone in fetal and adult animals. Stain Technol. 1981;56:271–273. doi: 10.3109/10520298109067325. [DOI] [PubMed] [Google Scholar]
  12. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569–574. doi: 10.1038/33345. [DOI] [PubMed] [Google Scholar]
  13. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708–713. doi: 10.1038/19531. [DOI] [PubMed] [Google Scholar]
  14. Rai R, Zheng H, He H, Luo Y, Multani A, Carpenter PB, Chang S. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J. 2010;29:2598–2610. doi: 10.1038/emboj.2010.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 1999;96:701–712. doi: 10.1016/s0092-8674(00)80580-2. [DOI] [PubMed] [Google Scholar]
  16. Su X, Paris M, Gi YJ, Tsai KY, Cho MS, Lin YL, Biernaskie JA, Sinha S, Prives C, Pevny LH, Miller FD, Flores ER. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell. 2009;5:64–75. doi: 10.1016/j.stem.2009.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z, Elvin JA, Bronson RT, Crum CP, McKeon F. p63 protects the female germ line during meiotic arrest. Nature. 2006;444:624–628. doi: 10.1038/nature05337. [DOI] [PubMed] [Google Scholar]
  18. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT) Biotechniques. 2000;29:52–54. doi: 10.2144/00291bm09. [DOI] [PubMed] [Google Scholar]
  19. Vlangos CN, O’Connor BC, Morley MJ, Krause AS, Osawa GA, Keegan CE. Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis. Dev Biol. 2009;334:418–428. doi: 10.1016/j.ydbio.2009.07.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature. 2007;445:506–510. doi: 10.1038/nature05454. [DOI] [PubMed] [Google Scholar]
  21. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O’Connor MS, Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature. 2007;445:559–562. doi: 10.1038/nature05469. [DOI] [PubMed] [Google Scholar]
  22. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305–316. doi: 10.1016/s1097-2765(00)80275-0. [DOI] [PubMed] [Google Scholar]
  23. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714–718. doi: 10.1038/19539. [DOI] [PubMed] [Google Scholar]
  24. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002;18:90–95. doi: 10.1016/s0168-9525(02)02595-7. [DOI] [PubMed] [Google Scholar]

RESOURCES